The role of interferon alpha 2b as an adjunctive treatment in the management of aggressive basal cell carcinoma of the eyelids [3]

Acta Ophthalmologica Scandinavica

Volumn 80, Issue 6, 2002, Pages 674-675

  Fenton, S ^a   Kennedy, S ^a   Moriarty, P ^a  

^a ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; INTERLEUKIN 2; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CORNEA RODENT ULCER; DRUG MECHANISM; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; INJECTION PAIN; LETTER; LEUKOPENIA; MALE; MYALGIA; PRIORITY JOURNAL; SKIN TRANSPLANTATION; SURGICAL TECHNIQUE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CHEMOTHERAPY, ADJUVANT; EYELID NEOPLASMS; FEMALE; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036919436     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800623_3.x     Document Type: Letter

References (9)

1. Chimenti S, Peris K, Di Cristofaro S et al. (1995): Use of recombinant interferon alpha-2b in the treatment of basal cell carcinoma. Dermatology 190(3): 214-217.
2. Cornell RC, Greenway HT, Tucker SB et al. (1990): Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 23: 694-700.
3. Greenway HT, Cornell RC, Tanner JT et al. (1986): Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 15(3): 437-443.
4. Johnson I-IM & Baron S (1976): The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol 25: 106-115.
5. Kim J Modlin RL, Dubinett SM et al. (1995): IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T-cell immune response. J Immunol 155(4): 2240-2247.
6. McGibbon DH (1985): Malignant epidermal tumours. J Cutan Pathol 12: 224-238.
7. Ortega JA, Ma A, Shore NA et al. (1979): Suppressive effect of interferon on erythroid cell proliferation. Exp Haematol 7: 145-150.
8. Rowe DE, Carroll RJ, Day CL Jr (1989): Long-term recurrence rates in previously untreated primary basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 3: 315-328.
9. Wickramasinghe L, Hindson TC & Wacks H (1989): Treatment of neoplastic lesions with intralesional interferon. J Am Acad Dermatol 20(1): 71-74.